参考文献/References:
[1]孙亚茹,吴振永,孙璐,等.血清CysC和Hcy检测早期诊断2型糖尿病肾病的价值[J].现代中西医结合杂志,2018,27(23):2592-2596.[2]Elsayed MS,El Badawy A,Ahmed A,et al.Serum cystatin C as an indicator for early detection of diabetic nephropathy in type 2 diabetes mellitus[J].Diabetes Metab Syndr,2019,13(1):374-381.[3]彭健韫,金菊,项美娟,等.血清及尿液生化指标对糖尿病肾病的早期诊断价值分析[J].浙江医学,2022,44(13):1397-1401,1466.[4]吕治安,王娟妮,杨艳艳.TIMP-2、TAFI与CyPA水平联合检测用于肾衰竭疾病相关进程的临床价值分析[J].中国中西医结合肾病杂志,2022,23(1):30-32.[5]邱友燕,夏碧文.血清胱抑素C与尿微量清蛋白/肌酐的检测在2型糖尿病肾病中的临床意义[J].检验医学与临床,2021,18(23):3451-3453.[6]邓琳,龚鸿昌,黄华,等.肾血管阻力指数、血清胱抑素C、肌酐水平对危重症患者早期急性肾损伤的预测价值[J].山东医药,2021,61(34):87-90.[7]中华医学会肾脏病学分会专家组.糖尿病肾脏疾病临床诊疗中国指南[J].中华肾脏病杂志,2021,37(3):255-304.[8]中华医学会糖尿病学分会.中国2型糖尿病防治指南(2020年版)[J].中华内分泌代谢杂志,2021,37(4):311-398.[9]宋继英.血清C-反应蛋白和胱抑素-C检测在2型糖尿病肾病早期诊断中的价值[J].中国实验诊断学,2020,24(11):1851-1853.[10]方芳,汪宏,耿克明,等.血清Cys C、RBP和尿mALB检测对肾小球滤过功能及肾功能损伤诊断分析[J].现代生物医学进展,2020,20(15):2983-2986.[11]钟凯丽.胱抑素C、血肌酐联合尿肌酐、尿素氮检测对代谢综合征患者早期肾损害的诊断价值[J].检验医学与临床,2019,16(21):3204-3207.[12]徐晏玲,艾禾,漆丹平.血清Hcy、CysC、RBP及尿足细胞联合检测对2型糖尿病肾病早期诊断的临床价值[J].海南医学,2021,32(22):2907-2909.[13]喻敏,刘春雅,罗林峰,等.血清同型半胱氨酸、胱抑素C和尿足细胞检测在Ⅱ型糖尿病肾病的早期诊断中的作用分析[J].中国卫生检验杂志,2019,29(16):1984-1986.[14]何强,师磊,吴金良.胱抑素C、尿微量总蛋白及肌酐诊断妊娠期糖尿病早期肾损害的价值[J].中国妇幼保健,2019,34(11):2472-2474.[15]黄焕宜,谢淑贤,肖树荣,等.血清CysC、Hcy和尿ALB/Cr检测对糖尿病肾病的早期诊断价值[J].中华保健医学杂志,2019,21(2):183-184.[16]Cao YF,Li J,Zhang Z,et al.Plasma Levels of Amino Acids Related to Urea Cycle and Risk of Type 2 Diabetes Mellitus in Chinese Adults[J].Front Endocrinol (Lausanne),2019,10:50.[17]缪淑贤,颜群,卢英,等.血清肌酐、尿素、尿酸和胱抑素C在肾功能损伤的诊断价值[J].江苏医药,2018,44(6):661-663.[18]李萍,王少敏,陈俊清,等.2型糖尿病肾病患者血清胱抑素C、β2微球蛋白以及脂蛋白(a)与尿微量白蛋白/尿肌酐的相关性探讨[J].现代中西医结合杂志,2018,27(35):3948-3951.[19]伍伟飞.血清胱抑素C和肾小管损伤标志物对急性肾损伤诊断价值的研究[J].浙江医学,2018,40(11):1226-1230,1235.[20]张蕾,韩艳秋.血清胱抑素C、糖化血红蛋白及尿微量白蛋白联合检测在2型糖尿病早期肾损伤中的临床价值[J].内蒙古医科大学学报,2018,40(2):117-120.[21]张如霖,王弘明,彭霞,等.血清淀粉样蛋白A、胱抑素C与尿白蛋白/肌酐比值联合检测在早期糖尿病肾病中的诊断价值[J].检验医学,2018,33(2):97-100.[22]鲍舟君,李翊卫,姚燕珍,等.血清三叶因子3水平联合尿素、肌酐、胱抑素C及肾小球滤过率估算值在糖尿病肾病诊断中的临床价值探讨[J].中国卫生检验杂志,2021,31(1):18-23.[23]邱丰胜.血清半胱氨酸蛋白酶抑制剂尿素氮血肌酐尿微量白蛋白联合检测在早期诊断肾脏疾病中的价值研究[J].山西医药杂志,2022,51(14):1661-1663.
相似文献/References:
[1]陈淑雯.肾衰宁联合科素亚治疗早期糖尿病肾病的临床观察[J].医学信息,2018,31(05):20.[doi:10.3969/j.issn.1006-1959.2018.05.007]
CHEN Shu-wen.Clinical Observation on Early Diabetic Nephropathy Treated by Shenshuaining Combined with Kosu[J].Journal of Medical Information,2018,31(09):20.[doi:10.3969/j.issn.1006-1959.2018.05.007]
[2]何丽杰.中西医治疗糖尿病肾病的临床效果分析[J].医学信息,2018,31(10):149.[doi:10.3969/j.issn.1006-1959.2018.10.051]
HE Li-jie.Clinical Effect Analysis of Diabetic Nephropathy Treated by Chinese and Western Medicine[J].Journal of Medical Information,2018,31(09):149.[doi:10.3969/j.issn.1006-1959.2018.10.051]
[3]贺 伟,高 峰.24 h尿微量白蛋白、血清胱抑素C水平与血清肌酐、尿素水平在2型糖尿病肾病早期诊断的意义[J].医学信息,2018,31(11):151.[doi:10.3969/j.issn.1006-1959.2018.11.049]
HE Wei,GAO Feng.The Significance of 24 h Urinary Microalbumin,Serum Cystatin C and Serum Creatinine and Urea Levels in the Early Diagnosis of Type 2 Diabetic Nephropathy[J].Journal of Medical Information,2018,31(09):151.[doi:10.3969/j.issn.1006-1959.2018.11.049]
[4]黄秋菊.胱抑素C及脂蛋白α在早期糖尿病肾病诊断中的价值研究[J].医学信息,2018,31(14):57.[doi:10.3969/j.issn.1006-1959.2018.14.018]
HUANG Qiu-ju.The Value of Cystatin C and Lipoprotein α in the Diagnosis of Early Diabetic Nephropathy[J].Journal of Medical Information,2018,31(09):57.[doi:10.3969/j.issn.1006-1959.2018.14.018]
[5]陆新虹,温玉洁,胡 欣,等.α-硫辛酸对2型糖尿病肾病患者
血清内脂素的影响研究[J].医学信息,2018,31(14):60.[doi:10.3969/j.issn.1006-1959.2018.14.019]
LU Xin-hong,WEN Yu-jie,HU Xin,et al.Effect of α-lipoic Acid on Serum Visfatin in Patients with
Type 2 Diabetic Nephropathy[J].Journal of Medical Information,2018,31(09):60.[doi:10.3969/j.issn.1006-1959.2018.14.019]
[6]郑小鹏,辛 华.糖尿病肾病研究进展[J].医学信息,2018,31(16):26.[doi:10.3969/j.issn.1006-1959.2018.16.008]
ZHENG Xiao-peng,XIN Hua.Progress in the Study of Diabetic Nephropathy[J].Journal of Medical Information,2018,31(09):26.[doi:10.3969/j.issn.1006-1959.2018.16.008]
[7]李志俊,王 利,王 浩.姜黄素改善糖尿病肾病的作用机制研究[J].医学信息,2018,31(24):35.[doi:10.3969/j.issn.1006-1959.2018.24.010]
LI Zhi-jun,WANG Li,WANG Hao.Study on the Mechanism of Curcumin in Improving Diabetic Nephropathy[J].Journal of Medical Information,2018,31(09):35.[doi:10.3969/j.issn.1006-1959.2018.24.010]
[8]肖学秀.益气活血汤联合西药治疗早期糖尿病肾病的临床观察[J].医学信息,2019,32(02):166.[doi:10.3969/j.issn.1006-1959.2019.02.051]
XIAO Xue-xiu.Clinical Observation of Yiqi Huoxue Decoction Combined with Western Medicine in Treating Earlyn Diabetic Nephropathy[J].Journal of Medical Information,2019,32(09):166.[doi:10.3969/j.issn.1006-1959.2019.02.051]
[9]张国艳,张佳田,隋洪玉.糖尿病肾病大鼠动物模型建立及INF-α干预机制研究[J].医学信息,2019,32(05):101.[doi:10.3969/j.issn.1006-1959.2019.05.030]
ZHANG Guo-yan,ZHANG Jia-tian,SUI Hong-yu.Establishment of Animal Model of Diabetic Nephropathy Rats and Study of INF-α Intervention Mechanism[J].Journal of Medical Information,2019,32(09):101.[doi:10.3969/j.issn.1006-1959.2019.05.030]
[10]吴怡琪,卢 文.皮肤AGEs荧光检测对糖尿病肾病的临床意义[J].医学信息,2019,32(06):101.[doi:10.3969/j.issn.1006-1959.2019.06.031]
WU Yi-qi,LU Wen.Clinical Significance of Skin AGEs Fluorescence Detection in Diabetic Kidney Disease[J].Journal of Medical Information,2019,32(09):101.[doi:10.3969/j.issn.1006-1959.2019.06.031]